GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Sale Of Business

Longevity Biomedical (Longevity Biomedical) Sale Of Business : $ Mil (TTM As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Sale Of Business?

Longevity Biomedical's sale of business for the six months ended in . 20 was $0.00 Mil. It means Longevity Biomedical gained $0.00 Mil from selling business. Longevity Biomedical does not have enough years/quarters to calculate the sale of business for the trailing twelve months (TTM) ended in . 20.

Compared with last quarter ($0.00 Mil in . 20 ), Longevity Biomedical gained the same money from selling business in . 20 ($0.00 Mil).


Longevity Biomedical Sale Of Business Historical Data

The historical data trend for Longevity Biomedical's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Sale Of Business Chart

Longevity Biomedical Annual Data
Trend
Sale Of Business

Longevity Biomedical Semi-Annual Data
Sale Of Business

Longevity Biomedical Sale Of Business Calculation

The amount earned to sell business.



Longevity Biomedical Sale Of Business Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines